Strides Pharma

RegulatoryJuly 28, 2026

FDA Grants AP Status for Levetiracetam Supplement by Strides Pharma

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for a supplement of levetiracetam submitted by Strides Pharma.

RegulatoryJuly 20, 2026

FDA Grants AP Status for Doxycycline ANDA202778 by Strides Pharma

The FDA has granted Abbreviated Approval (AP) status for the Doxycycline ANDA202778 submitted by Strides Pharma.

RegulatoryJuly 20, 2026

FDA Accepts Supplemental Application for Methotrexate Sodium by Strides Pharma

The FDA has accepted a supplemental application for Methotrexate Sodium submitted by Strides Pharma.

RegulatoryJuly 5, 2026

FDA Grants AP Status for Levetiracetam Supplement by Strides Pharma

The FDA has granted Abbreviated Approval (AP) status for a supplement application of levetiracetam submitted by Strides Pharma.

RegulatoryJuly 1, 2026

Strides Pharma's Piroxicam ANDA206136 Receives AP Status from FDA

Strides Pharma's ANDA for Piroxicam has received an Abbreviated Approval (AP) status from the FDA.

RegulatoryJune 28, 2026

FDA Approval Update for Hydrocodone Bitartrate and Acetaminophen by Strides Pharma

The FDA has granted an approval status (AP) for the ANDA040355 application for Hydrocodone Bitartrate and Acetaminophen submitted by Strides Pharma.

RegulatoryJune 28, 2026

FDA Approval for Morphine Sulfate Supplement by Strides Pharma

The FDA has approved a supplemental application for Morphine Sulfate submitted by Strides Pharma.

RegulatoryJune 28, 2026

FDA Approval Update for Tramadol Hydrochloride Supplement by Strides Pharma

Strides Pharma International has received an approval status for the supplemental application of Tramadol Hydrochloride.

RegulatoryJune 26, 2026

FDA Approval Status for Morphine Sulfate ANDA200812 by Strides Pharma

The FDA has granted approval status (AP) for ANDA200812, a morphine sulfate product from Strides Pharma.

RegulatoryJune 25, 2026

FDA Approves Oxycodone Hydrochloride Supplement by Strides Pharma

The FDA has approved a supplemental application for Oxycodone Hydrochloride submitted by Strides Pharma.

RegulatoryJune 21, 2026

FDA Grants AP Status for Losartan Potassium ANDA090382 by Strides Pharma

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Losartan Potassium submitted by Strides Pharma.

RegulatoryJune 8, 2026

FDA Approval Process Update for Mycophenolate Mofetil by Strides Pharma

The FDA has an active application (ANDA212634) for Mycophenolate Mofetil submitted by Strides Pharma, currently under standard review.

Recent signals(13)

FDA Grants AP Status for Levetiracetam Supplement by Strides Pharma

FDA Grants AP Status for Doxycycline ANDA202778 by Strides Pharma

FDA Accepts Supplemental Application for Methotrexate Sodium by Strides Pharma

FDA Grants AP Status for Levetiracetam Supplement by Strides Pharma

Strides Pharma's Piroxicam ANDA206136 Receives AP Status from FDA

FDA Grants AP Status for Piroxicam ANDA210347 by Strides Pharma

FDA Approval Update for Hydrocodone Bitartrate and Acetaminophen by Strides Pharma

FDA Approval for Morphine Sulfate Supplement by Strides Pharma

FDA Approval Update for Tramadol Hydrochloride Supplement by Strides Pharma

FDA Approval Status for Morphine Sulfate ANDA200812 by Strides Pharma

FDA Approves Oxycodone Hydrochloride Supplement by Strides Pharma

FDA Grants AP Status for Losartan Potassium ANDA090382 by Strides Pharma

FDA Approval Process Update for Mycophenolate Mofetil by Strides Pharma

Upcoming catalysts

Regulatory activity(12)

FDA Grants AP Status for Levetiracetam Supplement by Strides Pharma

FDA Grants AP Status for Doxycycline ANDA202778 by Strides Pharma

FDA Accepts Supplemental Application for Methotrexate Sodium by Strides Pharma

FDA Grants AP Status for Levetiracetam Supplement by Strides Pharma

Strides Pharma's Piroxicam ANDA206136 Receives AP Status from FDA

FDA Approval Update for Hydrocodone Bitartrate and Acetaminophen by Strides Pharma

FDA Approval for Morphine Sulfate Supplement by Strides Pharma

FDA Approval Update for Tramadol Hydrochloride Supplement by Strides Pharma

FDA Approval Status for Morphine Sulfate ANDA200812 by Strides Pharma

FDA Approves Oxycodone Hydrochloride Supplement by Strides Pharma

FDA Grants AP Status for Losartan Potassium ANDA090382 by Strides Pharma

FDA Approval Process Update for Mycophenolate Mofetil by Strides Pharma

Clinical activity

Competitive activity

Assets

Therapeutic areas

Indications

Get signals before the market moves